

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.49981247 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.49981247 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 6.49981247 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 6.49981247 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 6.49981247 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.49981247 |
| 7 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.85511950 |
| 8 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.42141066 |
| 9 | macrophage activation involved in immune response (GO:0002281) | 4.41753033 |
| 10 | neutrophil activation involved in immune response (GO:0002283) | 4.26546622 |
| 11 | DNA deamination (GO:0045006) | 4.23173012 |
| 12 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.10277403 |
| 13 | response to host immune response (GO:0052572) | 4.10277403 |
| 14 | microglial cell activation (GO:0001774) | 3.98267426 |
| 15 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.83165752 |
| 16 | response to host (GO:0075136) | 3.83165752 |
| 17 | response to host defenses (GO:0052200) | 3.83165752 |
| 18 | positive regulation of interferon-alpha production (GO:0032727) | 3.82422190 |
| 19 | proteasome assembly (GO:0043248) | 3.73172679 |
| 20 | response to peptidoglycan (GO:0032494) | 3.72101696 |
| 21 | hemidesmosome assembly (GO:0031581) | 3.68731182 |
| 22 | COPI coating of Golgi vesicle (GO:0048205) | 3.66768916 |
| 23 | Golgi transport vesicle coating (GO:0048200) | 3.66768916 |
| 24 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.63506435 |
| 25 | regulation of interferon-alpha production (GO:0032647) | 3.60905138 |
| 26 | regulation of cholesterol storage (GO:0010885) | 3.54424961 |
| 27 | platelet dense granule organization (GO:0060155) | 3.53523231 |
| 28 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.53234791 |
| 29 | low-density lipoprotein particle clearance (GO:0034383) | 3.50958280 |
| 30 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.50038170 |
| 31 | amyloid precursor protein catabolic process (GO:0042987) | 3.37577851 |
| 32 | apoptotic cell clearance (GO:0043277) | 3.35179427 |
| 33 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 3.32204300 |
| 34 | mannosylation (GO:0097502) | 3.28874735 |
| 35 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.23255484 |
| 36 | amino sugar catabolic process (GO:0046348) | 3.21659207 |
| 37 | negative regulation of response to reactive oxygen species (GO:1901032) | 3.14301206 |
| 38 | desmosome organization (GO:0002934) | 3.12197854 |
| 39 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.12100847 |
| 40 | response to lipoprotein particle (GO:0055094) | 3.09810323 |
| 41 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.08425997 |
| 42 | keratan sulfate catabolic process (GO:0042340) | 3.03164651 |
| 43 | macrophage activation (GO:0042116) | 3.02099988 |
| 44 | eosinophil migration (GO:0072677) | 3.01697658 |
| 45 | sphingosine metabolic process (GO:0006670) | 3.01429706 |
| 46 | keratinocyte development (GO:0003334) | 2.98020048 |
| 47 | response to muramyl dipeptide (GO:0032495) | 2.93239896 |
| 48 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.93071332 |
| 49 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.92346361 |
| 50 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.92069686 |
| 51 | adhesion of symbiont to host cell (GO:0044650) | 2.91851942 |
| 52 | virion attachment to host cell (GO:0019062) | 2.91851942 |
| 53 | pinocytosis (GO:0006907) | 2.91656967 |
| 54 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.91186897 |
| 55 | immunoglobulin mediated immune response (GO:0016064) | 2.89592321 |
| 56 | I-kappaB phosphorylation (GO:0007252) | 2.85189237 |
| 57 | negative regulation of protein autophosphorylation (GO:0031953) | 2.83548198 |
| 58 | skin morphogenesis (GO:0043589) | 2.82422365 |
| 59 | N-acetylneuraminate metabolic process (GO:0006054) | 2.81965727 |
| 60 | lysosome organization (GO:0007040) | 2.81028191 |
| 61 | lytic vacuole organization (GO:0080171) | 2.81028191 |
| 62 | regulation of hippo signaling (GO:0035330) | 2.80840361 |
| 63 | zinc ion transmembrane transport (GO:0071577) | 2.80669808 |
| 64 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.80585205 |
| 65 | positive regulation of antigen processing and presentation (GO:0002579) | 2.77392691 |
| 66 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.76800548 |
| 67 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.76390365 |
| 68 | regulation of sequestering of triglyceride (GO:0010889) | 2.75814925 |
| 69 | detection of molecule of bacterial origin (GO:0032490) | 2.75556882 |
| 70 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.75091516 |
| 71 | positive regulation of interferon-beta production (GO:0032728) | 2.75089213 |
| 72 | adhesion of symbiont to host (GO:0044406) | 2.73845637 |
| 73 | alanine transport (GO:0032328) | 2.73076332 |
| 74 | regulation of metalloenzyme activity (GO:0048552) | 2.71733055 |
| 75 | plasma lipoprotein particle clearance (GO:0034381) | 2.70372957 |
| 76 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.68709071 |
| 77 | diol metabolic process (GO:0034311) | 2.66459172 |
| 78 | negative regulation of lipid storage (GO:0010888) | 2.66361190 |
| 79 | myeloid cell activation involved in immune response (GO:0002275) | 2.65979871 |
| 80 | mannose metabolic process (GO:0006013) | 2.62934558 |
| 81 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.62767369 |
| 82 | phospholipid homeostasis (GO:0055091) | 2.62736378 |
| 83 | granulocyte activation (GO:0036230) | 2.62406641 |
| 84 | protein localization to endosome (GO:0036010) | 2.62228160 |
| 85 | GDP-mannose metabolic process (GO:0019673) | 2.61874058 |
| 86 | regulation of heat generation (GO:0031650) | 2.61548730 |
| 87 | sphingoid metabolic process (GO:0046519) | 2.61424588 |
| 88 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.61422222 |
| 89 | neutrophil activation (GO:0042119) | 2.61401641 |
| 90 | lipoprotein transport (GO:0042953) | 2.61347229 |
| 91 | regulation of mononuclear cell migration (GO:0071675) | 2.61287898 |
| 92 | cell adhesion mediated by integrin (GO:0033627) | 2.59612568 |
| 93 | zinc ion transport (GO:0006829) | 2.58720870 |
| 94 | modification by symbiont of host morphology or physiology (GO:0044003) | 2.58666354 |
| 95 | serine transport (GO:0032329) | 2.57336620 |
| 96 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.57175831 |
| 97 | respiratory burst (GO:0045730) | 2.55913681 |
| 98 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.55739978 |
| 99 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.54804118 |
| 100 | amyloid precursor protein metabolic process (GO:0042982) | 2.53017359 |
| 101 | neutrophil mediated immunity (GO:0002446) | 2.52543910 |
| 102 | vagina development (GO:0060068) | 2.52249787 |
| 103 | endosome to melanosome transport (GO:0035646) | 2.52101494 |
| 104 | endosome to pigment granule transport (GO:0043485) | 2.52101494 |
| 105 | pH reduction (GO:0045851) | 2.50886439 |
| 106 | cellular zinc ion homeostasis (GO:0006882) | 2.50317550 |
| 107 | L-amino acid import (GO:0043092) | 2.50082298 |
| 108 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.48281976 |
| 109 | phagosome maturation (GO:0090382) | 2.48245125 |
| 110 | lipopolysaccharide metabolic process (GO:0008653) | 2.48179583 |
| 111 | C-terminal protein lipidation (GO:0006501) | 2.47463151 |
| 112 | intracellular pH reduction (GO:0051452) | 2.46669267 |
| 113 | L-serine transport (GO:0015825) | 2.46112288 |
| 114 | wound healing, spreading of epidermal cells (GO:0035313) | 2.45781195 |
| 115 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.45197002 |
| 116 | oligosaccharide catabolic process (GO:0009313) | 2.44911812 |
| 117 | positive regulation of lipid storage (GO:0010884) | 2.43878521 |
| 118 | amino acid import (GO:0043090) | 2.43309808 |
| 119 | positive regulation of p38MAPK cascade (GO:1900745) | 2.43259723 |
| 120 | galactose metabolic process (GO:0006012) | 2.43224263 |
| 121 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.43068153 |
| 122 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.42593859 |
| 123 | type B pancreatic cell proliferation (GO:0044342) | 2.42023599 |
| 124 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.41391884 |
| 125 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.40695613 |
| 126 | L-phenylalanine metabolic process (GO:0006558) | 2.40528265 |
| 127 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.40528265 |
| 128 | positive regulation of heat generation (GO:0031652) | 2.40268150 |
| 129 | membrane raft organization (GO:0031579) | 2.40056854 |
| 130 | basic amino acid transport (GO:0015802) | 2.39682155 |
| 131 | negative regulation of interleukin-17 production (GO:0032700) | 2.38853654 |
| 132 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.38748481 |
| 133 | regulation of mast cell degranulation (GO:0043304) | 2.37817272 |
| 134 | regulation of water loss via skin (GO:0033561) | 2.37033322 |
| 135 | negative regulation of macroautophagy (GO:0016242) | 2.36168146 |
| 136 | positive regulation of mast cell activation (GO:0033005) | 2.35857142 |
| 137 | regulation of antigen processing and presentation (GO:0002577) | 2.35772394 |
| 138 | C-terminal protein amino acid modification (GO:0018410) | 2.35474021 |
| 139 | regulation of fever generation (GO:0031620) | 2.34763802 |
| 140 | signal peptide processing (GO:0006465) | 2.34653803 |
| 141 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.34596547 |
| 142 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.34172386 |
| 143 | positive regulation of macrophage cytokine production (GO:0060907) | 2.32214276 |
| 144 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.32153496 |
| 145 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.30893285 |
| 146 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.30893285 |
| 147 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.30074669 |
| 148 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.29849597 |
| 149 | glycosphingolipid metabolic process (GO:0006687) | 2.29146212 |
| 150 | autophagic vacuole fusion (GO:0000046) | 2.29030285 |
| 151 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.28948671 |
| 152 | galactose catabolic process (GO:0019388) | 2.28178697 |
| 153 | protein maturation by protein folding (GO:0022417) | 2.28167285 |
| 154 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 2.27618151 |
| 155 | fucose metabolic process (GO:0006004) | 2.27438244 |
| 156 | norepinephrine metabolic process (GO:0042415) | 2.26620583 |
| 157 | positive regulation of leukocyte degranulation (GO:0043302) | 2.26336695 |
| 158 | membrane lipid catabolic process (GO:0046466) | 2.26001176 |
| 159 | glycosphingolipid catabolic process (GO:0046479) | 2.25441806 |
| 160 | response to testosterone (GO:0033574) | 2.25437927 |
| 161 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.25119000 |
| 162 | ER overload response (GO:0006983) | 2.24982034 |
| 163 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.24528060 |
| 164 | nucleotide transmembrane transport (GO:1901679) | 2.24333334 |
| 165 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.23698333 |
| 166 | natural killer cell mediated immunity (GO:0002228) | 2.23405094 |
| 167 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.23405094 |
| 168 | sphingolipid catabolic process (GO:0030149) | 2.23053453 |
| 169 | macroautophagy (GO:0016236) | 2.22955600 |
| 170 | L-methionine salvage (GO:0071267) | 2.22824410 |
| 171 | L-methionine biosynthetic process (GO:0071265) | 2.22824410 |
| 172 | amino acid salvage (GO:0043102) | 2.22824410 |
| 173 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.22690604 |
| 174 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.22170527 |
| 175 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.21888395 |
| 176 | zinc ion homeostasis (GO:0055069) | 2.20156136 |
| 177 | regulation of interleukin-8 secretion (GO:2000482) | 2.18814888 |
| 178 | glucosamine-containing compound catabolic process (GO:1901072) | 2.18487931 |
| 179 | positive regulation of B cell differentiation (GO:0045579) | 2.17713959 |
| 180 | phagocytosis, recognition (GO:0006910) | 2.16449253 |
| 181 | negative regulation of mast cell activation (GO:0033004) | 2.16353732 |
| 182 | eosinophil chemotaxis (GO:0048245) | 2.15467898 |
| 183 | cytidine metabolic process (GO:0046087) | 2.15201490 |
| 184 | cytidine catabolic process (GO:0006216) | 2.15201490 |
| 185 | cytidine deamination (GO:0009972) | 2.15201490 |
| 186 | wound healing, spreading of cells (GO:0044319) | 2.13870348 |
| 187 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.13377192 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.83890316 |
| 2 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.27245043 |
| 3 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.83727372 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.71450571 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.45671431 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.44925077 |
| 7 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.24716374 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.20743147 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.94069504 |
| 10 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.88341746 |
| 11 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.84085535 |
| 12 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.79333665 |
| 13 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.63857563 |
| 14 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.55956312 |
| 15 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.42044500 |
| 16 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.40777609 |
| 17 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.40489844 |
| 18 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.34124543 |
| 19 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.21866320 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.20052205 |
| 21 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.18130388 |
| 22 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.17045489 |
| 23 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.12571182 |
| 24 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 2.06935998 |
| 25 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.05418319 |
| 26 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.05410030 |
| 27 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.00563147 |
| 28 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.98292627 |
| 29 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.96906190 |
| 30 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.90258331 |
| 31 | SPI1_23127762_ChIP-Seq_K562_Human | 1.86311832 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.83566815 |
| 33 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.83560255 |
| 34 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.82202279 |
| 35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.81116501 |
| 36 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.78081717 |
| 37 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.77298384 |
| 38 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.77221694 |
| 39 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.75014009 |
| 40 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.74955158 |
| 41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.72707162 |
| 42 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.72544551 |
| 43 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.71358139 |
| 44 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.70284616 |
| 45 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.70284616 |
| 46 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.68833973 |
| 47 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.66079497 |
| 48 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.63507299 |
| 49 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.63380755 |
| 50 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.61914643 |
| 51 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.58646235 |
| 52 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.58321714 |
| 53 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.57579250 |
| 54 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.56096937 |
| 55 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.54132724 |
| 56 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.52480386 |
| 57 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.52248157 |
| 58 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.50681371 |
| 59 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.49966987 |
| 60 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.47995691 |
| 61 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.43983079 |
| 62 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.42849971 |
| 63 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.42738885 |
| 64 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.38431362 |
| 65 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.38392835 |
| 66 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.38088568 |
| 67 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.37618823 |
| 68 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.37478103 |
| 69 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.37432030 |
| 70 | ATF3_27146783_Chip-Seq_COLON_Human | 1.36612940 |
| 71 | GATA1_22025678_ChIP-Seq_K562_Human | 1.33119555 |
| 72 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.32309719 |
| 73 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.28885899 |
| 74 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.27972055 |
| 75 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.27972055 |
| 76 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.27093840 |
| 77 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.26803414 |
| 78 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.25811554 |
| 79 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.25015273 |
| 80 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25010013 |
| 81 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.25009364 |
| 82 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24911277 |
| 83 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.24637857 |
| 84 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.22714023 |
| 85 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.21009018 |
| 86 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.20678045 |
| 87 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.19525489 |
| 88 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.19394842 |
| 89 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.18943367 |
| 90 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.17549243 |
| 91 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.17549243 |
| 92 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.15248382 |
| 93 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.15198088 |
| 94 | CJUN_26792858_Chip-Seq_BT549_Human | 1.14782832 |
| 95 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.13606187 |
| 96 | GATA1_19941826_ChIP-Seq_K562_Human | 1.13338524 |
| 97 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.13037629 |
| 98 | GATA2_19941826_ChIP-Seq_K562_Human | 1.12677292 |
| 99 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.10734801 |
| 100 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.10561682 |
| 101 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10297681 |
| 102 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09905226 |
| 103 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.09666427 |
| 104 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.08782585 |
| 105 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.08731084 |
| 106 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07656943 |
| 107 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.07529091 |
| 108 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.07249471 |
| 109 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.06195295 |
| 110 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.04963944 |
| 111 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04924165 |
| 112 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.03800909 |
| 113 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.03237607 |
| 114 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.02916023 |
| 115 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.02278971 |
| 116 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01741435 |
| 117 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.01397075 |
| 118 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.01268890 |
| 119 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.01126244 |
| 120 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.00196788 |
| 121 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99951845 |
| 122 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99718434 |
| 123 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.99527109 |
| 124 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.99225584 |
| 125 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.98939002 |
| 126 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.98491155 |
| 127 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98472013 |
| 128 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.98273027 |
| 129 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.97318367 |
| 130 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97267871 |
| 131 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.97262660 |
| 132 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.97179974 |
| 133 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.96397782 |
| 134 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.93804137 |
| 135 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.93444498 |
| 136 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.93403959 |
| 137 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.92941317 |
| 138 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92881397 |
| 139 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92795423 |
| 140 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.92470411 |
| 141 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.91669961 |
| 142 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.91555476 |
| 143 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91283770 |
| 144 | RXR_22108803_ChIP-Seq_LS180_Human | 0.91227875 |
| 145 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91158051 |
| 146 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.90990395 |
| 147 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90758092 |
| 148 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.90430824 |
| 149 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.90064652 |
| 150 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.90006406 |
| 151 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.89037179 |
| 152 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.88678891 |
| 153 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.88523403 |
| 154 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.88089064 |
| 155 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.87515153 |
| 156 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.86808288 |
| 157 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.86498736 |
| 158 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.85542345 |
| 159 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.84605227 |
| 160 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.82265547 |
| 161 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.81943010 |
| 162 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.81568259 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 4.97992027 |
| 2 | MP0009840_abnormal_foam_cell | 4.33177958 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 3.29280999 |
| 4 | MP0003172_abnormal_lysosome_physiology | 3.13339924 |
| 5 | MP0006054_spinal_hemorrhage | 2.89311730 |
| 6 | MP0003191_abnormal_cellular_cholesterol | 2.65979481 |
| 7 | MP0003690_abnormal_glial_cell | 2.60392099 |
| 8 | MP0000569_abnormal_digit_pigmentation | 2.51893926 |
| 9 | MP0000604_amyloidosis | 2.45800556 |
| 10 | MP0004510_myositis | 2.33955555 |
| 11 | MP0002419_abnormal_innate_immunity | 2.31418828 |
| 12 | MP0003436_decreased_susceptibility_to | 2.30963932 |
| 13 | MP0003303_peritoneal_inflammation | 2.29289100 |
| 14 | MP0000015_abnormal_ear_pigmentation | 2.28373516 |
| 15 | MP0008438_abnormal_cutaneous_collagen | 2.25771601 |
| 16 | MP0008875_abnormal_xenobiotic_pharmacok | 2.22202795 |
| 17 | MP0010234_abnormal_vibrissa_follicle | 2.20804801 |
| 18 | MP0006082_CNS_inflammation | 2.18746509 |
| 19 | MP0000538_abnormal_urinary_bladder | 2.12802986 |
| 20 | MP0010386_abnormal_urinary_bladder | 2.08873122 |
| 21 | MP0001835_abnormal_antigen_presentation | 2.03653346 |
| 22 | MP0002254_reproductive_system_inflammat | 2.01598832 |
| 23 | MP0000343_altered_response_to | 1.99499393 |
| 24 | MP0003279_aneurysm | 1.96209934 |
| 25 | MP0003566_abnormal_cell_adhesion | 1.94284133 |
| 26 | MP0001661_extended_life_span | 1.92696348 |
| 27 | MP0004272_abnormal_basement_membrane | 1.84778255 |
| 28 | MP0003646_muscle_fatigue | 1.83834056 |
| 29 | MP0003950_abnormal_plasma_membrane | 1.81903056 |
| 30 | MP0005365_abnormal_bile_salt | 1.81241585 |
| 31 | MP0004130_abnormal_muscle_cell | 1.81205458 |
| 32 | MP0003011_delayed_dark_adaptation | 1.80571437 |
| 33 | MP0005408_hypopigmentation | 1.77333676 |
| 34 | MP0003075_altered_response_to | 1.68061058 |
| 35 | MP0005257_abnormal_intraocular_pressure | 1.67781138 |
| 36 | MP0001533_abnormal_skeleton_physiology | 1.66869562 |
| 37 | MP0003300_gastrointestinal_ulcer | 1.64971535 |
| 38 | MP0000371_diluted_coat_color | 1.62714523 |
| 39 | MP0002877_abnormal_melanocyte_morpholog | 1.61649784 |
| 40 | MP0002148_abnormal_hypersensitivity_rea | 1.60924067 |
| 41 | MP0001958_emphysema | 1.58185657 |
| 42 | MP0003705_abnormal_hypodermis_morpholog | 1.57089701 |
| 43 | MP0000427_abnormal_hair_cycle | 1.55374322 |
| 44 | MP0003656_abnormal_erythrocyte_physiolo | 1.53244849 |
| 45 | MP0004233_abnormal_muscle_weight | 1.51698170 |
| 46 | MP0002060_abnormal_skin_morphology | 1.51272885 |
| 47 | MP0009785_altered_susceptibility_to | 1.50516275 |
| 48 | MP0004019_abnormal_vitamin_homeostasis | 1.50454169 |
| 49 | MP0005000_abnormal_immune_tolerance | 1.48322493 |
| 50 | MP0005025_abnormal_response_to | 1.46468492 |
| 51 | MP0000516_abnormal_urinary_system | 1.45281733 |
| 52 | MP0005367_renal/urinary_system_phenotyp | 1.45281733 |
| 53 | MP0003195_calcinosis | 1.45168490 |
| 54 | MP0003091_abnormal_cell_migration | 1.43371670 |
| 55 | MP0000920_abnormal_myelination | 1.40948149 |
| 56 | MP0005167_abnormal_blood-brain_barrier | 1.39837507 |
| 57 | MP0005387_immune_system_phenotype | 1.39757268 |
| 58 | MP0001790_abnormal_immune_system | 1.39757268 |
| 59 | MP0002909_abnormal_adrenal_gland | 1.39499309 |
| 60 | MP0005464_abnormal_platelet_physiology | 1.39327383 |
| 61 | MP0001853_heart_inflammation | 1.37907586 |
| 62 | MP0000372_irregular_coat_pigmentation | 1.37278332 |
| 63 | MP0005083_abnormal_biliary_tract | 1.37056674 |
| 64 | MP0002452_abnormal_antigen_presenting | 1.35231303 |
| 65 | MP0002876_abnormal_thyroid_physiology | 1.33767813 |
| 66 | MP0001542_abnormal_bone_strength | 1.33604179 |
| 67 | MP0003724_increased_susceptibility_to | 1.32888043 |
| 68 | MP0003183_abnormal_peptide_metabolism | 1.32626756 |
| 69 | MP0002998_abnormal_bone_remodeling | 1.32036502 |
| 70 | MP0009764_decreased_sensitivity_to | 1.29460424 |
| 71 | MP0010678_abnormal_skin_adnexa | 1.28911268 |
| 72 | MP0003786_premature_aging | 1.27973436 |
| 73 | MP0003329_amyloid_beta_deposits | 1.27777682 |
| 74 | MP0000751_myopathy | 1.27682801 |
| 75 | MP0005171_absent_coat_pigmentation | 1.26755244 |
| 76 | MP0005023_abnormal_wound_healing | 1.26425972 |
| 77 | MP0004381_abnormal_hair_follicle | 1.25142800 |
| 78 | MP0004947_skin_inflammation | 1.23838609 |
| 79 | MP0009278_abnormal_bone_marrow | 1.23535034 |
| 80 | MP0008469_abnormal_protein_level | 1.22996452 |
| 81 | MP0003448_altered_tumor_morphology | 1.21686814 |
| 82 | MP0001216_abnormal_epidermal_layer | 1.21414086 |
| 83 | MP0001849_ear_inflammation | 1.18403852 |
| 84 | MP0000383_abnormal_hair_follicle | 1.17187189 |
| 85 | MP0008260_abnormal_autophagy | 1.16937931 |
| 86 | MP0004084_abnormal_cardiac_muscle | 1.15249946 |
| 87 | MP0000749_muscle_degeneration | 1.14827322 |
| 88 | MP0002723_abnormal_immune_serum | 1.14134001 |
| 89 | MP0005360_urolithiasis | 1.12731819 |
| 90 | MP0000685_abnormal_immune_system | 1.11962564 |
| 91 | MP0002837_dystrophic_cardiac_calcinosis | 1.11871222 |
| 92 | MP0004858_abnormal_nervous_system | 1.11731908 |
| 93 | MP0000750_abnormal_muscle_regeneration | 1.11294061 |
| 94 | MP0003634_abnormal_glial_cell | 1.10667778 |
| 95 | MP0002139_abnormal_hepatobiliary_system | 1.09115708 |
| 96 | MP0000647_abnormal_sebaceous_gland | 1.08689611 |
| 97 | MP0005332_abnormal_amino_acid | 1.08429232 |
| 98 | MP0005075_abnormal_melanosome_morpholog | 1.08082214 |
| 99 | MP0001243_abnormal_dermal_layer | 1.07088484 |
| 100 | MP0005085_abnormal_gallbladder_physiolo | 1.06718646 |
| 101 | MP0003828_pulmonary_edema | 1.06346462 |
| 102 | MP0001800_abnormal_humoral_immune | 1.00702289 |
| 103 | MP0005166_decreased_susceptibility_to | 0.99073922 |
| 104 | MP0005165_increased_susceptibility_to | 0.98822887 |
| 105 | MP0008775_abnormal_heart_ventricle | 0.98626579 |
| 106 | MP0002972_abnormal_cardiac_muscle | 0.98330691 |
| 107 | MP0003186_abnormal_redox_activity | 0.98169487 |
| 108 | MP0002098_abnormal_vibrissa_morphology | 0.98010766 |
| 109 | MP0005330_cardiomyopathy | 0.96892104 |
| 110 | MP0010329_abnormal_lipoprotein_level | 0.96202523 |
| 111 | MP0004185_abnormal_adipocyte_glucose | 0.96111479 |
| 112 | MP0009643_abnormal_urine_homeostasis | 0.95974646 |
| 113 | MP0001845_abnormal_inflammatory_respons | 0.95969909 |
| 114 | MP0000858_altered_metastatic_potential | 0.95901288 |
| 115 | MP0000358_abnormal_cell_content/ | 0.95599083 |
| 116 | MP0000467_abnormal_esophagus_morphology | 0.94989388 |
| 117 | MP0002075_abnormal_coat/hair_pigmentati | 0.94578140 |
| 118 | MP0002090_abnormal_vision | 0.94527803 |
| 119 | MP0005666_abnormal_adipose_tissue | 0.94317834 |
| 120 | MP0000767_abnormal_smooth_muscle | 0.93651331 |
| 121 | MP0001756_abnormal_urination | 0.93173034 |
| 122 | MP0002896_abnormal_bone_mineralization | 0.93090327 |
| 123 | MP0009780_abnormal_chondrocyte_physiolo | 0.92691151 |
| 124 | MP0003045_fibrosis | 0.92543823 |
| 125 | MP0004087_abnormal_muscle_fiber | 0.92365926 |
| 126 | MP0010771_integument_phenotype | 0.92239997 |
| 127 | MP0002332_abnormal_exercise_endurance | 0.92149157 |
| 128 | MP0001819_abnormal_immune_cell | 0.91823616 |
| 129 | MP0005174_abnormal_tail_pigmentation | 0.91775654 |
| 130 | MP0003136_yellow_coat_color | 0.91308045 |
| 131 | MP0002118_abnormal_lipid_homeostasis | 0.90936610 |
| 132 | MP0000609_abnormal_liver_physiology | 0.90880981 |
| 133 | MP0002971_abnormal_brown_adipose | 0.90733921 |
| 134 | MP0000377_abnormal_hair_follicle | 0.90603779 |
| 135 | MP0002420_abnormal_adaptive_immunity | 0.89381710 |
| 136 | MP0005197_abnormal_uvea_morphology | 0.88293291 |
| 137 | MP0009763_increased_sensitivity_to | 0.87729181 |
| 138 | MP0001324_abnormal_eye_pigmentation | 0.87540670 |
| 139 | MP0000579_abnormal_nail_morphology | 0.87266277 |
| 140 | MP0005319_abnormal_enzyme/_coenzyme | 0.87239435 |
| 141 | MP0005670_abnormal_white_adipose | 0.86787827 |
| 142 | MP0004215_abnormal_myocardial_fiber | 0.84389659 |
| 143 | MP0005595_abnormal_vascular_smooth | 0.83969958 |
| 144 | MP0005310_abnormal_salivary_gland | 0.83864884 |
| 145 | MP0005390_skeleton_phenotype | 0.83125035 |
| 146 | MP0001186_pigmentation_phenotype | 0.82556576 |
| 147 | MP0001544_abnormal_cardiovascular_syste | 0.82498121 |
| 148 | MP0005385_cardiovascular_system_phenoty | 0.82498121 |
| 149 | MP0000367_abnormal_coat/_hair | 0.82428761 |
| 150 | MP0002168_other_aberrant_phenotype | 0.82206223 |
| 151 | MP0005164_abnormal_response_to | 0.80517912 |
| 152 | MP0000249_abnormal_blood_vessel | 0.80207215 |
| 153 | MP0002295_abnormal_pulmonary_circulatio | 0.80200079 |
| 154 | MP0005451_abnormal_body_composition | 0.79730509 |
| 155 | MP0002102_abnormal_ear_morphology | 0.78792034 |
| 156 | MP0005275_abnormal_skin_tensile | 0.78623865 |
| 157 | MP0003453_abnormal_keratinocyte_physiol | 0.77779259 |
| 158 | MP0003252_abnormal_bile_duct | 0.77050401 |
| 159 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.75772752 |
| 160 | MP0005501_abnormal_skin_physiology | 0.74160153 |
| 161 | MP0000627_abnormal_mammary_gland | 0.71917642 |
| 162 | MP0005508_abnormal_skeleton_morphology | 0.71881298 |
| 163 | MP0001873_stomach_inflammation | 0.71423582 |
| 164 | MP0005671_abnormal_response_to | 0.70837067 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased cerebral lipofuscin (HP:0011813) | 5.81711921 |
| 2 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.97459937 |
| 3 | Recurrent abscess formation (HP:0002722) | 4.78428608 |
| 4 | Axonal loss (HP:0003447) | 4.72196046 |
| 5 | Vacuolated lymphocytes (HP:0001922) | 4.62687802 |
| 6 | Abnormality of macrophages (HP:0004311) | 4.35877265 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 4.32279639 |
| 8 | Dysostosis multiplex (HP:0000943) | 4.06781886 |
| 9 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.04692344 |
| 10 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.04692344 |
| 11 | Abnormality of glycolipid metabolism (HP:0010969) | 4.04692344 |
| 12 | Systemic lupus erythematosus (HP:0002725) | 3.95736628 |
| 13 | Eczematoid dermatitis (HP:0000976) | 3.76535998 |
| 14 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.59478395 |
| 15 | Loss of speech (HP:0002371) | 3.56984159 |
| 16 | Myocardial infarction (HP:0001658) | 3.55237363 |
| 17 | Neurofibrillary tangles (HP:0002185) | 3.42624616 |
| 18 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.42044299 |
| 19 | Mucopolysacchariduria (HP:0008155) | 3.33660686 |
| 20 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.33660686 |
| 21 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.31414086 |
| 22 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.31414086 |
| 23 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.31414086 |
| 24 | Hypokinesia (HP:0002375) | 3.25154492 |
| 25 | Asymmetric septal hypertrophy (HP:0001670) | 3.13907880 |
| 26 | Cervical subluxation (HP:0003308) | 3.06229186 |
| 27 | Tetraparesis (HP:0002273) | 3.01454489 |
| 28 | Tongue fasciculations (HP:0001308) | 2.98741777 |
| 29 | Xanthomatosis (HP:0000991) | 2.89343010 |
| 30 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.85054272 |
| 31 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.85054272 |
| 32 | Abnormal protein glycosylation (HP:0012346) | 2.85054272 |
| 33 | Abnormal glycosylation (HP:0012345) | 2.85054272 |
| 34 | Type I transferrin isoform profile (HP:0003642) | 2.82360603 |
| 35 | Vascular calcification (HP:0004934) | 2.81578886 |
| 36 | Gingivitis (HP:0000230) | 2.71975447 |
| 37 | Thick nail (HP:0001805) | 2.68676898 |
| 38 | Cutaneous melanoma (HP:0012056) | 2.68546874 |
| 39 | Cardiovascular calcification (HP:0011915) | 2.62006563 |
| 40 | Hypoalphalipoproteinemia (HP:0003233) | 2.58344337 |
| 41 | Glomerulonephritis (HP:0000099) | 2.57376965 |
| 42 | Autoimmune thrombocytopenia (HP:0001973) | 2.52720972 |
| 43 | Premature rupture of membranes (HP:0001788) | 2.50534951 |
| 44 | Cerebral inclusion bodies (HP:0100314) | 2.50136727 |
| 45 | Large for gestational age (HP:0001520) | 2.49728626 |
| 46 | Muscle fibrillation (HP:0010546) | 2.49416891 |
| 47 | Disinhibition (HP:0000734) | 2.48594098 |
| 48 | Recurrent skin infections (HP:0001581) | 2.46989933 |
| 49 | Osteolytic defects of the hand bones (HP:0009699) | 2.44566721 |
| 50 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.44566721 |
| 51 | Peripheral demyelination (HP:0011096) | 2.42448240 |
| 52 | Hyperlipoproteinemia (HP:0010980) | 2.39675361 |
| 53 | Supranuclear gaze palsy (HP:0000605) | 2.36534241 |
| 54 | Amyloidosis (HP:0011034) | 2.35033792 |
| 55 | Poor head control (HP:0002421) | 2.29391517 |
| 56 | Basal ganglia calcification (HP:0002135) | 2.29134394 |
| 57 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.27385510 |
| 58 | Urticaria (HP:0001025) | 2.26514008 |
| 59 | Turricephaly (HP:0000262) | 2.25424857 |
| 60 | Prolonged neonatal jaundice (HP:0006579) | 2.25390006 |
| 61 | Nuclear cataract (HP:0100018) | 2.22332538 |
| 62 | Pathologic fracture (HP:0002756) | 2.21033946 |
| 63 | Hepatosplenomegaly (HP:0001433) | 2.19799613 |
| 64 | Hypoplasia of the odontoid process (HP:0003311) | 2.19518764 |
| 65 | Short nail (HP:0001799) | 2.19002618 |
| 66 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.18618485 |
| 67 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.18618485 |
| 68 | Neuronal loss in central nervous system (HP:0002529) | 2.14903914 |
| 69 | Entropion (HP:0000621) | 2.12768003 |
| 70 | Plantar hyperkeratosis (HP:0007556) | 2.11788553 |
| 71 | Stomatitis (HP:0010280) | 2.11273924 |
| 72 | Complement deficiency (HP:0004431) | 2.10474219 |
| 73 | Alopecia of scalp (HP:0002293) | 2.09338135 |
| 74 | Opisthotonus (HP:0002179) | 2.08453790 |
| 75 | J-shaped sella turcica (HP:0002680) | 2.07425581 |
| 76 | Cerebral aneurysm (HP:0004944) | 2.06668462 |
| 77 | Fragile nails (HP:0001808) | 2.05735284 |
| 78 | Global brain atrophy (HP:0002283) | 2.05021183 |
| 79 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.04832522 |
| 80 | Cardiomegaly (HP:0001640) | 2.04534868 |
| 81 | Hamartoma of the eye (HP:0010568) | 2.04038118 |
| 82 | Muscle fiber splitting (HP:0003555) | 2.03853454 |
| 83 | Onycholysis (HP:0001806) | 2.03091001 |
| 84 | Sparse eyelashes (HP:0000653) | 2.01993794 |
| 85 | Beaking of vertebral bodies (HP:0004568) | 2.01607250 |
| 86 | Vertebral compression fractures (HP:0002953) | 2.00816343 |
| 87 | Nephritis (HP:0000123) | 1.99951341 |
| 88 | Hypercholesterolemia (HP:0003124) | 1.99609826 |
| 89 | Abnormality of proline metabolism (HP:0010907) | 1.98848313 |
| 90 | Hydroxyprolinuria (HP:0003080) | 1.98848313 |
| 91 | Ventricular tachycardia (HP:0004756) | 1.98433892 |
| 92 | Retinal atrophy (HP:0001105) | 1.98161452 |
| 93 | Orchitis (HP:0100796) | 1.97644403 |
| 94 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.97306607 |
| 95 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.97245520 |
| 96 | Abnormality of complement system (HP:0005339) | 1.93738207 |
| 97 | Albinism (HP:0001022) | 1.93549126 |
| 98 | Bone pain (HP:0002653) | 1.93077177 |
| 99 | Aplasia involving bones of the extremities (HP:0009825) | 1.92890178 |
| 100 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.92890178 |
| 101 | Aplasia of the phalanges of the hand (HP:0009802) | 1.92890178 |
| 102 | Mediastinal lymphadenopathy (HP:0100721) | 1.92820577 |
| 103 | Premature loss of primary teeth (HP:0006323) | 1.90801602 |
| 104 | Increased serum ferritin (HP:0003281) | 1.89755735 |
| 105 | Distal lower limb muscle weakness (HP:0009053) | 1.89407217 |
| 106 | Upper motor neuron abnormality (HP:0002127) | 1.89271428 |
| 107 | Increased connective tissue (HP:0009025) | 1.88093761 |
| 108 | Atrophic scars (HP:0001075) | 1.87091075 |
| 109 | Bone cyst (HP:0012062) | 1.86775725 |
| 110 | Nausea (HP:0002018) | 1.86520813 |
| 111 | Skin nodule (HP:0200036) | 1.86502488 |
| 112 | Spastic paraparesis (HP:0002313) | 1.86384201 |
| 113 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.86346279 |
| 114 | Hyporeflexia of lower limbs (HP:0002600) | 1.85388491 |
| 115 | Sudden death (HP:0001699) | 1.85209988 |
| 116 | Progressive visual loss (HP:0000529) | 1.84595142 |
| 117 | Amelogenesis imperfecta (HP:0000705) | 1.82932058 |
| 118 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.82431720 |
| 119 | Right ventricular cardiomyopathy (HP:0011663) | 1.82281236 |
| 120 | Paraparesis (HP:0002385) | 1.81535734 |
| 121 | Exercise-induced muscle cramps (HP:0003710) | 1.81136629 |
| 122 | Palmoplantar hyperkeratosis (HP:0000972) | 1.79526493 |
| 123 | Ovoid vertebral bodies (HP:0003300) | 1.78916449 |
| 124 | Abnormality of the odontoid process (HP:0003310) | 1.78641705 |
| 125 | Mesangial abnormality (HP:0001966) | 1.78322388 |
| 126 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.78041729 |
| 127 | Protuberant abdomen (HP:0001538) | 1.77908008 |
| 128 | Myositis (HP:0100614) | 1.77411297 |
| 129 | Periodontitis (HP:0000704) | 1.77031222 |
| 130 | Progressive neurologic deterioration (HP:0002344) | 1.75499521 |
| 131 | Delayed gross motor development (HP:0002194) | 1.75074502 |
| 132 | Natal tooth (HP:0000695) | 1.73170950 |
| 133 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.71906374 |
| 134 | Disproportionate short-trunk short stature (HP:0003521) | 1.71692115 |
| 135 | Concave nail (HP:0001598) | 1.69930768 |
| 136 | Personality changes (HP:0000751) | 1.68944649 |
| 137 | Esophageal neoplasm (HP:0100751) | 1.68729517 |
| 138 | Neoplasm of head and neck (HP:0012288) | 1.68729517 |
| 139 | Clumsiness (HP:0002312) | 1.67520904 |
| 140 | Pustule (HP:0200039) | 1.67025155 |
| 141 | Ketoacidosis (HP:0001993) | 1.66876314 |
| 142 | Distal lower limb amyotrophy (HP:0008944) | 1.66545405 |
| 143 | Nail dystrophy (HP:0008404) | 1.66399131 |
| 144 | Abnormality of iron homeostasis (HP:0011031) | 1.66163462 |
| 145 | Methylmalonic aciduria (HP:0012120) | 1.66124606 |
| 146 | Sensorimotor neuropathy (HP:0007141) | 1.66032080 |
| 147 | Apathy (HP:0000741) | 1.66025434 |
| 148 | Deformed sella turcica (HP:0002681) | 1.65997884 |
| 149 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.65426090 |
| 150 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.64571828 |
| 151 | Abnormality of the lumbar spine (HP:0100712) | 1.64280357 |
| 152 | Keratoconus (HP:0000563) | 1.64070551 |
| 153 | Increased corneal curvature (HP:0100692) | 1.64070551 |
| 154 | Congenital, generalized hypertrichosis (HP:0004540) | 1.63749233 |
| 155 | Mitral stenosis (HP:0001718) | 1.63301082 |
| 156 | Broad face (HP:0000283) | 1.60484612 |
| 157 | Microretrognathia (HP:0000308) | 1.59600146 |
| 158 | Generalized amyotrophy (HP:0003700) | 1.58925306 |
| 159 | Rough bone trabeculation (HP:0100670) | 1.58779614 |
| 160 | Distal upper limb amyotrophy (HP:0007149) | 1.57904581 |
| 161 | Upper limb amyotrophy (HP:0009129) | 1.57904581 |
| 162 | Hematochezia (HP:0002573) | 1.57260754 |
| 163 | Follicular hyperkeratosis (HP:0007502) | 1.56973291 |
| 164 | Aortic valve stenosis (HP:0001650) | 1.56867953 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA2 | 3.55909003 |
| 2 | TTN | 3.43132379 |
| 3 | MAPKAPK3 | 3.36471402 |
| 4 | IRAK3 | 3.35218597 |
| 5 | TRIB3 | 3.28258855 |
| 6 | FRK | 2.93163246 |
| 7 | ERN1 | 2.81813577 |
| 8 | BLK | 2.65133479 |
| 9 | EPHB1 | 2.59381805 |
| 10 | TBK1 | 2.57414146 |
| 11 | RIPK4 | 2.56139659 |
| 12 | LIMK1 | 2.44800094 |
| 13 | KIT | 2.40674440 |
| 14 | MAP3K12 | 2.37012053 |
| 15 | RIPK1 | 2.36821088 |
| 16 | TYK2 | 2.32150190 |
| 17 | ADRBK2 | 2.24380502 |
| 18 | MAP2K3 | 2.19649958 |
| 19 | PAK4 | 2.11490167 |
| 20 | PBK | 2.10666337 |
| 21 | MAP3K14 | 2.01798973 |
| 22 | TXK | 1.99858869 |
| 23 | MAP3K13 | 1.89955011 |
| 24 | IRAK4 | 1.88069296 |
| 25 | TESK2 | 1.84098220 |
| 26 | LMTK2 | 1.81511926 |
| 27 | FER | 1.74561546 |
| 28 | JAK1 | 1.71706976 |
| 29 | TGFBR2 | 1.67343471 |
| 30 | PHKG2 | 1.66330665 |
| 31 | PHKG1 | 1.66330665 |
| 32 | MUSK | 1.65450879 |
| 33 | CAMK1D | 1.53723292 |
| 34 | CAMK1G | 1.50897175 |
| 35 | TLK1 | 1.45359708 |
| 36 | STK10 | 1.44305699 |
| 37 | EPHB2 | 1.42726810 |
| 38 | TRPM7 | 1.41906755 |
| 39 | FGR | 1.38125397 |
| 40 | EIF2AK3 | 1.37671567 |
| 41 | DMPK | 1.35559269 |
| 42 | MAPK12 | 1.32547943 |
| 43 | TAOK3 | 1.29597264 |
| 44 | ACVR1B | 1.28089506 |
| 45 | PRKCI | 1.27737955 |
| 46 | IKBKE | 1.21099495 |
| 47 | IKBKB | 1.18742481 |
| 48 | PTK6 | 1.18652871 |
| 49 | MET | 1.14669543 |
| 50 | CSF1R | 1.12337690 |
| 51 | GRK1 | 1.11054105 |
| 52 | MST4 | 1.07014957 |
| 53 | HCK | 1.06639902 |
| 54 | CSK | 1.05490011 |
| 55 | WNK4 | 1.02864581 |
| 56 | JAK3 | 1.01993474 |
| 57 | BMX | 0.99735713 |
| 58 | PRKD2 | 0.99708511 |
| 59 | SIK1 | 0.97812703 |
| 60 | ADRBK1 | 0.96537379 |
| 61 | ABL2 | 0.93497862 |
| 62 | KDR | 0.91036642 |
| 63 | MST1R | 0.90348749 |
| 64 | JAK2 | 0.88829544 |
| 65 | CSNK1A1L | 0.88694330 |
| 66 | MAP3K5 | 0.88493902 |
| 67 | PDPK1 | 0.87083814 |
| 68 | SIK3 | 0.86211053 |
| 69 | PKN2 | 0.85292026 |
| 70 | MAP4K1 | 0.85172510 |
| 71 | GRK7 | 0.83656698 |
| 72 | BMPR1B | 0.82636545 |
| 73 | PDK2 | 0.78764303 |
| 74 | CSNK1G3 | 0.78298490 |
| 75 | MAPKAPK5 | 0.77933922 |
| 76 | ZAP70 | 0.77617498 |
| 77 | FES | 0.76505547 |
| 78 | LRRK2 | 0.75714116 |
| 79 | EIF2AK1 | 0.73127407 |
| 80 | PRKD1 | 0.72797521 |
| 81 | CHUK | 0.72253868 |
| 82 | NTRK1 | 0.71715607 |
| 83 | BUB1 | 0.68734372 |
| 84 | MAP2K6 | 0.64902170 |
| 85 | NUAK1 | 0.64475603 |
| 86 | GSK3A | 0.64023532 |
| 87 | ERBB4 | 0.63340602 |
| 88 | PRKCD | 0.63077567 |
| 89 | DAPK3 | 0.62977883 |
| 90 | MAP3K3 | 0.62686428 |
| 91 | FLT3 | 0.62488736 |
| 92 | STK39 | 0.62244404 |
| 93 | CAMKK2 | 0.60562026 |
| 94 | MOS | 0.60550964 |
| 95 | PKN1 | 0.59037818 |
| 96 | CAMK2G | 0.58288423 |
| 97 | STK4 | 0.58257049 |
| 98 | ARAF | 0.58091073 |
| 99 | ZAK | 0.57303679 |
| 100 | PRKCH | 0.57268766 |
| 101 | PAK6 | 0.57153058 |
| 102 | MAP4K2 | 0.57124541 |
| 103 | EIF2AK2 | 0.56546853 |
| 104 | MAP2K1 | 0.56431173 |
| 105 | PDGFRA | 0.56350493 |
| 106 | PDK1 | 0.55945946 |
| 107 | EGFR | 0.54554800 |
| 108 | TIE1 | 0.54375784 |
| 109 | MAPKAPK2 | 0.54335505 |
| 110 | KSR2 | 0.54150085 |
| 111 | ROCK1 | 0.54083775 |
| 112 | CSNK1G1 | 0.53627437 |
| 113 | BCKDK | 0.53003056 |
| 114 | ABL1 | 0.52968469 |
| 115 | PIM2 | 0.52106092 |
| 116 | VRK2 | 0.51512471 |
| 117 | TGFBR1 | 0.51062992 |
| 118 | NEK9 | 0.50934049 |
| 119 | LYN | 0.50379649 |
| 120 | STK38 | 0.50015842 |
| 121 | PRKAA2 | 0.49311373 |
| 122 | PIK3CA | 0.48733840 |
| 123 | PRKCE | 0.47886578 |
| 124 | CSNK1G2 | 0.46956066 |
| 125 | LCK | 0.46197427 |
| 126 | SYK | 0.45968205 |
| 127 | PTK2 | 0.45189738 |
| 128 | PAK2 | 0.44779854 |
| 129 | MELK | 0.43307362 |
| 130 | PDGFRB | 0.43116709 |
| 131 | MYLK | 0.42788656 |
| 132 | FYN | 0.42485723 |
| 133 | BRSK1 | 0.41607900 |
| 134 | PRKG2 | 0.41593999 |
| 135 | SGK3 | 0.41141928 |
| 136 | PAK3 | 0.40685003 |
| 137 | MAPK7 | 0.40155472 |
| 138 | IRAK1 | 0.40113341 |
| 139 | FGFR4 | 0.39661935 |
| 140 | ICK | 0.39507734 |
| 141 | PRKCQ | 0.39351127 |
| 142 | ILK | 0.39312027 |
| 143 | MAP3K2 | 0.38616494 |
| 144 | DAPK1 | 0.38302960 |
| 145 | NME2 | 0.38197107 |
| 146 | OBSCN | 0.37021294 |
| 147 | IGF1R | 0.36875748 |
| 148 | WNK1 | 0.36454761 |
| 149 | CAMK2D | 0.35809222 |
| 150 | INSRR | 0.35658421 |
| 151 | RPS6KA2 | 0.35321874 |
| 152 | MATK | 0.35228452 |
| 153 | DDR2 | 0.35171794 |
| 154 | MAP3K1 | 0.34570490 |
| 155 | CAMK2B | 0.34085408 |
| 156 | SRC | 0.33684526 |
| 157 | TESK1 | 0.31623802 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Lysosome_Homo sapiens_hsa04142 | 3.42032510 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.38831783 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.00904179 |
| 4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.79639440 |
| 5 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.64749494 |
| 6 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.60035660 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 2.23970029 |
| 8 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.20433642 |
| 9 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.14728806 |
| 10 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.07775986 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.04841963 |
| 12 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.96962435 |
| 13 | Malaria_Homo sapiens_hsa05144 | 1.94482600 |
| 14 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.92865252 |
| 15 | Phagosome_Homo sapiens_hsa04145 | 1.89835646 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.85557017 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.80951334 |
| 18 | Tuberculosis_Homo sapiens_hsa05152 | 1.77786335 |
| 19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.77187793 |
| 20 | Galactose metabolism_Homo sapiens_hsa00052 | 1.75653222 |
| 21 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.72939975 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.69820051 |
| 23 | Protein export_Homo sapiens_hsa03060 | 1.69305032 |
| 24 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.61882415 |
| 25 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.56807012 |
| 26 | Pertussis_Homo sapiens_hsa05133 | 1.53921905 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.49969270 |
| 28 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.41643838 |
| 29 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.41587645 |
| 30 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.37131399 |
| 31 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.36086442 |
| 32 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.35905460 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.31188267 |
| 34 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.28648831 |
| 35 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.26508150 |
| 36 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.21843297 |
| 37 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.19676529 |
| 38 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.18411205 |
| 39 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.17186537 |
| 40 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.14817410 |
| 41 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.13312455 |
| 42 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.13206070 |
| 43 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.12528662 |
| 44 | Legionellosis_Homo sapiens_hsa05134 | 1.12254539 |
| 45 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.12140457 |
| 46 | Salmonella infection_Homo sapiens_hsa05132 | 1.12039746 |
| 47 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.11467700 |
| 48 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.10726323 |
| 49 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.06658688 |
| 50 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.04346933 |
| 51 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.02899019 |
| 52 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.01828580 |
| 53 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.99723673 |
| 54 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.98829936 |
| 55 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.98547579 |
| 56 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.96659076 |
| 57 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.96507589 |
| 58 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.96431484 |
| 59 | Apoptosis_Homo sapiens_hsa04210 | 0.93993651 |
| 60 | RNA polymerase_Homo sapiens_hsa03020 | 0.92598792 |
| 61 | Peroxisome_Homo sapiens_hsa04146 | 0.92532228 |
| 62 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.91743002 |
| 63 | Viral myocarditis_Homo sapiens_hsa05416 | 0.91297745 |
| 64 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.90851139 |
| 65 | Shigellosis_Homo sapiens_hsa05131 | 0.90811593 |
| 66 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.90593065 |
| 67 | Mineral absorption_Homo sapiens_hsa04978 | 0.90193675 |
| 68 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.89307723 |
| 69 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.89209360 |
| 70 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.88434017 |
| 71 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.88322072 |
| 72 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.87460534 |
| 73 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.83379850 |
| 74 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.83333198 |
| 75 | Amoebiasis_Homo sapiens_hsa05146 | 0.82852810 |
| 76 | Influenza A_Homo sapiens_hsa05164 | 0.82297997 |
| 77 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.80198445 |
| 78 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.80038900 |
| 79 | Sulfur relay system_Homo sapiens_hsa04122 | 0.79530881 |
| 80 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.79463763 |
| 81 | Metabolic pathways_Homo sapiens_hsa01100 | 0.78333678 |
| 82 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.78112126 |
| 83 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.77749045 |
| 84 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.77534780 |
| 85 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.77380939 |
| 86 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.77340643 |
| 87 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.76765436 |
| 88 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.75527059 |
| 89 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.75098338 |
| 90 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.73447299 |
| 91 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.72608549 |
| 92 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.72145189 |
| 93 | Alzheimers disease_Homo sapiens_hsa05010 | 0.71377025 |
| 94 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.71281410 |
| 95 | Measles_Homo sapiens_hsa05162 | 0.70601137 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | 0.70381993 |
| 97 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.68029102 |
| 98 | Histidine metabolism_Homo sapiens_hsa00340 | 0.66247241 |
| 99 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.65668560 |
| 100 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.65397424 |
| 101 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.63259821 |
| 102 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.63145033 |
| 103 | Parkinsons disease_Homo sapiens_hsa05012 | 0.62911319 |
| 104 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.62524117 |
| 105 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.62448119 |
| 106 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.62377907 |
| 107 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.61363737 |
| 108 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.60737078 |
| 109 | Insulin resistance_Homo sapiens_hsa04931 | 0.60089681 |
| 110 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.58666161 |
| 111 | Endocytosis_Homo sapiens_hsa04144 | 0.58419180 |
| 112 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.57761113 |
| 113 | Carbon metabolism_Homo sapiens_hsa01200 | 0.56451057 |
| 114 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.56067701 |
| 115 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.55438720 |
| 116 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.54419386 |
| 117 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.52131758 |
| 118 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.51462217 |
| 119 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.51206832 |
| 120 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.51030379 |
| 121 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50615490 |
| 122 | ABC transporters_Homo sapiens_hsa02010 | 0.48838304 |
| 123 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.48826020 |
| 124 | Retinol metabolism_Homo sapiens_hsa00830 | 0.48670694 |
| 125 | Prion diseases_Homo sapiens_hsa05020 | 0.48093084 |
| 126 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.47915599 |
| 127 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.47093498 |
| 128 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.46926539 |
| 129 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.45671025 |
| 130 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.45354798 |
| 131 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.45306332 |
| 132 | Allograft rejection_Homo sapiens_hsa05330 | 0.44956102 |
| 133 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.44671076 |
| 134 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.44398065 |
| 135 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43124681 |
| 136 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.42991698 |
| 137 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.42545144 |
| 138 | Bile secretion_Homo sapiens_hsa04976 | 0.42248029 |
| 139 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.41397507 |
| 140 | Focal adhesion_Homo sapiens_hsa04510 | 0.41011108 |
| 141 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.40418644 |
| 142 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.39361947 |
| 143 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.39338972 |
| 144 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.38905225 |
| 145 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38758090 |
| 146 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.38196593 |
| 147 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.38000569 |
| 148 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.37326269 |
| 149 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.35701415 |
| 150 | Bladder cancer_Homo sapiens_hsa05219 | 0.34180202 |
| 151 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.28693583 |
| 152 | Huntingtons disease_Homo sapiens_hsa05016 | 0.23975298 |
| 153 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.22242417 |

